Human brain organoids successfully integrated in mice
人類大腦類器官成功植入小鼠體內
更新於: 2026年9月20日 上午02:00
Scientists have achieved a groundbreaking milestone in neuroscience: the successful integration of human brain organoids into mice.
科學家在神經科學領域達成了一個突破性的里程碑：成功將人類大腦類器官植入小鼠體內。
While 3D human brain organoids grown in laboratories are excellent tools, they previously struggled to mature fully without a circulatory system or physical space.
雖然在實驗室培育的 3D 人類大腦類器官是優秀的研究工具，但牠們過去在缺乏循環系統或物理空間的情況下，難以完全成熟。
In 2026, researchers at Stanford University overcame this by using genetically engineered 'apallial' mice, which lack parts of their own cortex and hippocampus.
2026 年，史丹佛大學的研究人員利用基因工程改造的「無皮質」(apallial)小鼠克服了此問題，這種小鼠缺乏部分大腦皮質和海馬迴。
This created the necessary space for the human organoids to thrive.
這為人類類器官的繁茂生長創造了必要的空間。
Remarkably, these organoids grew to occupy most of the cortical volume, developed their own blood vessels, and integrated into the mouse nervous system, even responding to sensory stimuli.
值得注意的是，這些類器官生長至佔據了大部分的大腦皮質空間，發展出自身的血管，並整合進小鼠的神經系統中，甚至能對感官刺激做出反應。
However, this progress brings profound ethical challenges.
然而，這項進展也帶來了深遠的倫理挑戰。
The creation of these chimeric animals raises questions about the potential for human-like sentience and the moral status of the creatures involved.
創造這些嵌合體動物引發了關於其是否具備人類般感知能力，以及相關生物道德地位的疑慮。
As researchers push the boundaries of medical science to better understand and treat conditions like neurodevelopmental disorders, the global scientific community continues to debate the balance between life-saving innovation and the ethical responsibilities of managing such hybrid models.
隨著研究人員不斷突破醫學界限，以期更好地理解並治療如神經發育障礙等疾病，全球科學界持續爭論在救命創新與管理此類混合模型應負的倫理責任之間，該如何取得平衡。
